Calcium Antagonists: Pharmacology and Clinical Research
Although the importance of calcium (Ca2+) in the maintenance of cardiac contractility was recognized as early as 1880, the critical role of the ion in the contractile process in skeletal, cardiac, and smooth muscle has only been established within the last three decades. As the complexity of the pha...
Gespeichert in:
| Weitere Verfasser: | , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Dordrecht
Springer Netherlands
1993
|
| Schriftenreihe: | Medical Science Symposia Series
3 |
| Schlagworte: | |
| Online-Zugang: | UBR01 URL des Erstveröffentlichers |
| Zusammenfassung: | Although the importance of calcium (Ca2+) in the maintenance of cardiac contractility was recognized as early as 1880, the critical role of the ion in the contractile process in skeletal, cardiac, and smooth muscle has only been established within the last three decades. As the complexity of the pharmacological actions of the Ca2+ channel inhibitors grows, there is a continued need to further clarify the inhibitors, both chemically and functionally. This volume provides an update of the field based on the work presented at the 5th International Symposium on Calcium Antagonists: Pharmacology and Clinical Research. It reviews the current state of the growing area of molecular biology of Ca2+ channels. In the cardiovascular area, in addition to the well-established clinical uses of Ca2+ channel inhibitors, exciting new work pointing to an application in atherosclerosis is described. The book also includes important uses of Ca2+ antagonists in novel areas of interest such as the gastrointestinal tract, renal protection and multi-drug resistance |
| Beschreibung: | 1 Online-Ressource (XXV, 381 p) |
| ISBN: | 9789401117258 |
| DOI: | 10.1007/978-94-011-1725-8 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046146376 | ||
| 003 | DE-604 | ||
| 005 | 20201026 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1993 |||| o||u| ||||||eng d | ||
| 020 | |a 9789401117258 |9 978-94-011-1725-8 | ||
| 024 | 7 | |a 10.1007/978-94-011-1725-8 |2 doi | |
| 035 | |a (ZDB-2-SME)978-94-011-1725-8 | ||
| 035 | |a (OCoLC)1119094271 | ||
| 035 | |a (DE-599)BVBBV046146376 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.12 |2 23 | |
| 084 | |a XI 4305 |0 (DE-625)153005:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Calcium Antagonists |b Pharmacology and Clinical Research |c edited by T. Godfraind, R. Paoletti, S. Govoni, P. M. Vanhoutte |
| 264 | 1 | |a Dordrecht |b Springer Netherlands |c 1993 | |
| 300 | |a 1 Online-Ressource (XXV, 381 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Medical Science Symposia Series |v 3 | |
| 520 | |a Although the importance of calcium (Ca2+) in the maintenance of cardiac contractility was recognized as early as 1880, the critical role of the ion in the contractile process in skeletal, cardiac, and smooth muscle has only been established within the last three decades. As the complexity of the pharmacological actions of the Ca2+ channel inhibitors grows, there is a continued need to further clarify the inhibitors, both chemically and functionally. This volume provides an update of the field based on the work presented at the 5th International Symposium on Calcium Antagonists: Pharmacology and Clinical Research. It reviews the current state of the growing area of molecular biology of Ca2+ channels. In the cardiovascular area, in addition to the well-established clinical uses of Ca2+ channel inhibitors, exciting new work pointing to an application in atherosclerosis is described. The book also includes important uses of Ca2+ antagonists in novel areas of interest such as the gastrointestinal tract, renal protection and multi-drug resistance | ||
| 650 | 4 | |a Cardiology | |
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Cardiology | |
| 650 | 4 | |a Toxicology | |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Calciumantagonist |0 (DE-588)4069807-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1991 |z Houston Tex. |2 gnd-content | |
| 689 | 0 | 0 | |a Calciumantagonist |0 (DE-588)4069807-5 |D s |
| 689 | 0 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Calciumantagonist |0 (DE-588)4069807-5 |D s |
| 689 | 1 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Godfraind, Théophile |d 1931- |0 (DE-588)1189706970 |4 edt | |
| 700 | 1 | |a Paoletti, Rodolfo |d 1931- |0 (DE-588)1089134606 |4 edt | |
| 700 | 1 | |a Govoni, Stefano |d 1950- |0 (DE-588)1218640855 |4 edt | |
| 700 | 1 | |a Vanhoutte, Paul M. |d 1940-2019 |0 (DE-588)110375599 |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780792322597 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789401047562 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789401117265 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-94-011-1725-8 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031526561 | ||
| 966 | e | |u https://doi.org/10.1007/978-94-011-1725-8 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180484253548544 |
|---|---|
| any_adam_object | |
| author2 | Godfraind, Théophile 1931- Paoletti, Rodolfo 1931- Govoni, Stefano 1950- Vanhoutte, Paul M. 1940-2019 |
| author2_role | edt edt edt edt |
| author2_variant | t g tg r p rp s g sg p m v pm pmv |
| author_GND | (DE-588)1189706970 (DE-588)1089134606 (DE-588)1218640855 (DE-588)110375599 |
| author_facet | Godfraind, Théophile 1931- Paoletti, Rodolfo 1931- Govoni, Stefano 1950- Vanhoutte, Paul M. 1940-2019 |
| building | Verbundindex |
| bvnumber | BV046146376 |
| classification_rvk | XI 4305 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-94-011-1725-8 (OCoLC)1119094271 (DE-599)BVBBV046146376 |
| dewey-full | 616.12 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.12 |
| dewey-search | 616.12 |
| dewey-sort | 3616.12 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-94-011-1725-8 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03474nmm a2200613zcb4500</leader><controlfield tag="001">BV046146376</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20201026 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1993 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789401117258</subfield><subfield code="9">978-94-011-1725-8</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-94-011-1725-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-94-011-1725-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119094271</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046146376</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.12</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 4305</subfield><subfield code="0">(DE-625)153005:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Calcium Antagonists</subfield><subfield code="b">Pharmacology and Clinical Research</subfield><subfield code="c">edited by T. Godfraind, R. Paoletti, S. Govoni, P. M. Vanhoutte</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht</subfield><subfield code="b">Springer Netherlands</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XXV, 381 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Medical Science Symposia Series</subfield><subfield code="v">3</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Although the importance of calcium (Ca2+) in the maintenance of cardiac contractility was recognized as early as 1880, the critical role of the ion in the contractile process in skeletal, cardiac, and smooth muscle has only been established within the last three decades. As the complexity of the pharmacological actions of the Ca2+ channel inhibitors grows, there is a continued need to further clarify the inhibitors, both chemically and functionally. This volume provides an update of the field based on the work presented at the 5th International Symposium on Calcium Antagonists: Pharmacology and Clinical Research. It reviews the current state of the growing area of molecular biology of Ca2+ channels. In the cardiovascular area, in addition to the well-established clinical uses of Ca2+ channel inhibitors, exciting new work pointing to an application in atherosclerosis is described. The book also includes important uses of Ca2+ antagonists in novel areas of interest such as the gastrointestinal tract, renal protection and multi-drug resistance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Calciumantagonist</subfield><subfield code="0">(DE-588)4069807-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1991</subfield><subfield code="z">Houston Tex.</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Calciumantagonist</subfield><subfield code="0">(DE-588)4069807-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Calciumantagonist</subfield><subfield code="0">(DE-588)4069807-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Godfraind, Théophile</subfield><subfield code="d">1931-</subfield><subfield code="0">(DE-588)1189706970</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Paoletti, Rodolfo</subfield><subfield code="d">1931-</subfield><subfield code="0">(DE-588)1089134606</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Govoni, Stefano</subfield><subfield code="d">1950-</subfield><subfield code="0">(DE-588)1218640855</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vanhoutte, Paul M.</subfield><subfield code="d">1940-2019</subfield><subfield code="0">(DE-588)110375599</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780792322597</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789401047562</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789401117265</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-94-011-1725-8</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031526561</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-94-011-1725-8</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1991 Houston Tex. gnd-content |
| genre_facet | Konferenzschrift 1991 Houston Tex. |
| id | DE-604.BV046146376 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:29Z |
| institution | BVB |
| isbn | 9789401117258 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031526561 |
| oclc_num | 1119094271 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XXV, 381 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | Springer Netherlands |
| record_format | marc |
| series2 | Medical Science Symposia Series |
| spelling | Calcium Antagonists Pharmacology and Clinical Research edited by T. Godfraind, R. Paoletti, S. Govoni, P. M. Vanhoutte Dordrecht Springer Netherlands 1993 1 Online-Ressource (XXV, 381 p) txt rdacontent c rdamedia cr rdacarrier Medical Science Symposia Series 3 Although the importance of calcium (Ca2+) in the maintenance of cardiac contractility was recognized as early as 1880, the critical role of the ion in the contractile process in skeletal, cardiac, and smooth muscle has only been established within the last three decades. As the complexity of the pharmacological actions of the Ca2+ channel inhibitors grows, there is a continued need to further clarify the inhibitors, both chemically and functionally. This volume provides an update of the field based on the work presented at the 5th International Symposium on Calcium Antagonists: Pharmacology and Clinical Research. It reviews the current state of the growing area of molecular biology of Ca2+ channels. In the cardiovascular area, in addition to the well-established clinical uses of Ca2+ channel inhibitors, exciting new work pointing to an application in atherosclerosis is described. The book also includes important uses of Ca2+ antagonists in novel areas of interest such as the gastrointestinal tract, renal protection and multi-drug resistance Cardiology Pharmacology/Toxicology Toxicology Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Calciumantagonist (DE-588)4069807-5 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1991 Houston Tex. gnd-content Calciumantagonist (DE-588)4069807-5 s Pharmakotherapie (DE-588)4076066-2 s DE-604 Pharmakologie (DE-588)4045687-0 s Godfraind, Théophile 1931- (DE-588)1189706970 edt Paoletti, Rodolfo 1931- (DE-588)1089134606 edt Govoni, Stefano 1950- (DE-588)1218640855 edt Vanhoutte, Paul M. 1940-2019 (DE-588)110375599 edt Erscheint auch als Druck-Ausgabe 9780792322597 Erscheint auch als Druck-Ausgabe 9789401047562 Erscheint auch als Druck-Ausgabe 9789401117265 https://doi.org/10.1007/978-94-011-1725-8 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Calcium Antagonists Pharmacology and Clinical Research Cardiology Pharmacology/Toxicology Toxicology Pharmakotherapie (DE-588)4076066-2 gnd Calciumantagonist (DE-588)4069807-5 gnd Pharmakologie (DE-588)4045687-0 gnd |
| subject_GND | (DE-588)4076066-2 (DE-588)4069807-5 (DE-588)4045687-0 (DE-588)1071861417 |
| title | Calcium Antagonists Pharmacology and Clinical Research |
| title_auth | Calcium Antagonists Pharmacology and Clinical Research |
| title_exact_search | Calcium Antagonists Pharmacology and Clinical Research |
| title_full | Calcium Antagonists Pharmacology and Clinical Research edited by T. Godfraind, R. Paoletti, S. Govoni, P. M. Vanhoutte |
| title_fullStr | Calcium Antagonists Pharmacology and Clinical Research edited by T. Godfraind, R. Paoletti, S. Govoni, P. M. Vanhoutte |
| title_full_unstemmed | Calcium Antagonists Pharmacology and Clinical Research edited by T. Godfraind, R. Paoletti, S. Govoni, P. M. Vanhoutte |
| title_short | Calcium Antagonists |
| title_sort | calcium antagonists pharmacology and clinical research |
| title_sub | Pharmacology and Clinical Research |
| topic | Cardiology Pharmacology/Toxicology Toxicology Pharmakotherapie (DE-588)4076066-2 gnd Calciumantagonist (DE-588)4069807-5 gnd Pharmakologie (DE-588)4045687-0 gnd |
| topic_facet | Cardiology Pharmacology/Toxicology Toxicology Pharmakotherapie Calciumantagonist Pharmakologie Konferenzschrift 1991 Houston Tex. |
| url | https://doi.org/10.1007/978-94-011-1725-8 |
| work_keys_str_mv | AT godfraindtheophile calciumantagonistspharmacologyandclinicalresearch AT paolettirodolfo calciumantagonistspharmacologyandclinicalresearch AT govonistefano calciumantagonistspharmacologyandclinicalresearch AT vanhouttepaulm calciumantagonistspharmacologyandclinicalresearch |